{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:18:37Z","timestamp":1783397917692,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007814","name":"Adiyaman University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007814","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11845-026-04373-4","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:53:03Z","timestamp":1776163983000},"page":"1377-1386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum cardiotrophin-1 and interleukin-17 levels in psoriasis"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-6266","authenticated-orcid":false,"given":"Fatma","family":"Sengul-Bag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-7737","authenticated-orcid":false,"given":"Fikret","family":"Akyurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6033-8816","authenticated-orcid":false,"given":"Halil","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-8331","authenticated-orcid":false,"given":"Fatma","family":"Tuncez-Akyurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"4373_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475. https:\/\/doi.org\/10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"4373_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020749","volume":"26","author":"OA Orzan","year":"2025","unstructured":"Orzan OA, Tutunaru CV, Ianosi SL (2025) Understanding the intricate pathophysiology of psoriasis and related skin disorders. Int J Mol Sci 26:749. https:\/\/doi.org\/10.3390\/ijms26020749","journal-title":"Int J Mol Sci"},{"key":"4373_CR3","doi-asserted-by":"publisher","first-page":"E5825","DOI":"10.1073\/pnas.1509971112","volume":"112","author":"C Johansen","year":"2015","unstructured":"Johansen C, Mose M, Ommen P et al (2015) I\u03bab\u03b6 is a key driver in the development of psoriasis. Proc Natl Acad Sci U S A 112:E5825-5833. https:\/\/doi.org\/10.1073\/pnas.1509971112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4373_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312793","volume":"22","author":"R Singh","year":"2021","unstructured":"Singh R, Koppu S, Perche PO, Feldman SR (2021) The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci 22:12793. https:\/\/doi.org\/10.3390\/ijms222312793","journal-title":"Int J Mol Sci"},{"key":"4373_CR5","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2147\/ccid.S420850","volume":"16","author":"M Wu","year":"2023","unstructured":"Wu M, Dai C, Zeng F (2023) Cellular mechanisms of psoriasis pathogenesis: a systemic review. Clin Cosmet Investig Dermatol 16:2503\u20132515. https:\/\/doi.org\/10.2147\/ccid.S420850","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4373_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin DA, Towne JE, Kricorian G et al (2013) The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 133:17\u201326. https:\/\/doi.org\/10.1038\/jid.2012.194","journal-title":"J Invest Dermatol"},{"key":"4373_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","volume":"10","author":"DJ Cua","year":"2010","unstructured":"Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479\u2013489. https:\/\/doi.org\/10.1038\/nri2800","journal-title":"Nat Rev Immunol"},{"key":"4373_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111511","volume":"9","author":"A Campanati","year":"2021","unstructured":"Campanati A, Marani A, Martina E et al (2021) Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines 9:1511. https:\/\/doi.org\/10.3390\/biomedicines9111511","journal-title":"Biomedicines"},{"key":"4373_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.11.001","volume":"32","author":"I Grozdev","year":"2014","unstructured":"Grozdev I, Korman N, Tsankov N (2014) Psoriasis as a systemic disease. Clin Dermatol 32:343\u2013350. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.11.001","journal-title":"Clin Dermatol"},{"key":"4373_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"4373_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","volume":"298","author":"DM Sommer","year":"2007","unstructured":"Sommer DM, Jenisch S, Suchan M et al (2007) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321\u2013328. https:\/\/doi.org\/10.1007\/s00403-006-0703-z","journal-title":"Arch Dermatol Res"},{"key":"4373_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011) The \u201cpsoriatic march\u201d: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303\u2013307. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x","journal-title":"Exp Dermatol"},{"key":"4373_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/j1010010","volume":"1","author":"T Watanabe","year":"2018","unstructured":"Watanabe T, Konii H, Sato K (2018) Emerging roles of cardiotrophin-1 in the pathogenesis and biomarker of atherosclerosis. J 1:94\u2013105. https:\/\/doi.org\/10.3390\/j1010010","journal-title":"J"},{"key":"4373_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yjmcc.2008.11.002","volume":"46","author":"P Calabr\u00f2","year":"2009","unstructured":"Calabr\u00f2 P, Limongelli G, Riegler L et al (2009) Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J Mol Cell Cardiol 46:142\u2013148. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.11.002","journal-title":"J Mol Cell Cardiol"},{"key":"4373_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1161\/HYPERTENSIONAHA.113.01653","volume":"62","author":"H Konii","year":"2013","unstructured":"Konii H, Sato K, Kikuchi S et al (2013) Stimulatory effects of cardiotrophin 1 on atherosclerosis. Hypertension 62:942\u2013950. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01653","journal-title":"Hypertension"},{"key":"4373_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/HJH.0b013e32831ac981","volume":"27","author":"B L\u00f3pez","year":"2009","unstructured":"L\u00f3pez B, Gonz\u00e1lez A, Querejeta R et al (2009) Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications. J Hypertens 27:418\u2013424. https:\/\/doi.org\/10.1097\/HJH.0b013e32831ac981","journal-title":"J Hypertens"},{"key":"4373_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/jch.12376","volume":"16","author":"K Song","year":"2014","unstructured":"Song K, Wang S, Huang B et al (2014) Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: a meta-analysis. J Clin Hypertens (Greenwich) 16:686\u2013692. https:\/\/doi.org\/10.1111\/jch.12376","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4373_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-2133.1999.02963.x","volume":"141","author":"DM Ashcroft","year":"1999","unstructured":"Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CEM (1999) Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 141:185\u2013191. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02963.x","journal-title":"Br J Dermatol"},{"key":"4373_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/cs0990083","volume":"99","author":"S Talwar","year":"2000","unstructured":"Talwar S, Squire IB, Downie PF et al (2000) Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci Lond 99:83\u201388","journal-title":"Clin Sci Lond"},{"key":"4373_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/hypertensionaha.107.098111","volume":"50","author":"B L\u00f3pez","year":"2007","unstructured":"L\u00f3pez B, Castellano JM, Gonz\u00e1lez A et al (2007) Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension. Hypertension 50:977\u2013983. https:\/\/doi.org\/10.1161\/hypertensionaha.107.098111","journal-title":"Hypertension"},{"key":"4373_CR21","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1152\/ajpendo.00506.2007","volume":"294","author":"C Natal","year":"2008","unstructured":"Natal C, Fortu\u00f1o MA, Restituto P et al (2008) Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab 294:E52-60. https:\/\/doi.org\/10.1152\/ajpendo.00506.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4373_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cytogfr.2015.07.009","volume":"26","author":"M L\u00f3pez-Yoldi","year":"2015","unstructured":"L\u00f3pez-Yoldi M, Moreno-Aliaga MJ, Bustos M (2015) Cardiotrophin-1: a multifaceted cytokine. Cytokine Growth Factor Rev 26:523\u2013532. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.009","journal-title":"Cytokine Growth Factor Rev"},{"key":"4373_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5507\/bp.2008.002","volume":"152","author":"D Stejskal","year":"2008","unstructured":"Stejskal D, Ruzicka V (2008) Cardiotrophin-1. Review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:9\u201319. https:\/\/doi.org\/10.5507\/bp.2008.002","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"4373_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","volume":"35","author":"H Takahashi","year":"2010","unstructured":"Takahashi H, Tsuji H, Hashimoto Y et al (2010) Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 35:645\u2013649. https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03704.x","journal-title":"Clin Exp Dermatol"},{"key":"4373_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00403-012-1229-1","volume":"304","author":"SB Yilmaz","year":"2012","unstructured":"Yilmaz SB, Cicek N, Coskun M et al (2012) Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis. Arch Dermatol Res 304:465\u2013469. https:\/\/doi.org\/10.1007\/s00403-012-1229-1","journal-title":"Arch Dermatol Res"},{"key":"4373_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/jewd.Jewd_29_19","volume":"16","author":"H Morsy","year":"2019","unstructured":"Morsy H, Hasaballa A, Awad S (2019) Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome. J Egypt Womens Dermatol Soc 16:164\u2013169. https:\/\/doi.org\/10.4103\/jewd.Jewd_29_19","journal-title":"J Egypt Womens Dermatol Soc"},{"key":"4373_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","volume":"73","author":"G Varricchi","year":"2015","unstructured":"Varricchi G, Granata F, Loffredo S et al (2015) Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol 73:144\u2013153. https:\/\/doi.org\/10.1016\/j.jaad.2015.03.041","journal-title":"J Am Acad Dermatol"},{"key":"4373_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/exd.13467","volume":"27","author":"JG Krueger","year":"2018","unstructured":"Krueger JG, Brunner PM (2018) Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities. Exp Dermatol 27:115\u2013123. https:\/\/doi.org\/10.1111\/exd.13467","journal-title":"Exp Dermatol"},{"key":"4373_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/ced.14335","volume":"46","author":"HS Midde","year":"2021","unstructured":"Midde HS, Priyadarssini M, Rajappa M et al (2021) Interleukin-9 serves as a key link between systemic inflammation and angiogenesis in psoriasis. Clin Exp Dermatol 46:50\u201357. https:\/\/doi.org\/10.1111\/ced.14335","journal-title":"Clin Exp Dermatol"},{"key":"4373_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","volume":"160","author":"C Johansen","year":"2009","unstructured":"Johansen C, Usher PA, Kjellerup RB et al (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 160:319\u2013324. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08902.x","journal-title":"Br J Dermatol"},{"key":"4373_CR31","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v105.43685","volume":"105","author":"CW Schwarz","year":"2025","unstructured":"Schwarz CW, N\u00e4slund-Koch C, Zachariae C et al (2025) Adverse events and immune response in psoriasis patients receiving interleukin-17 inhibitors. Acta Derm Venereol 105:adv43685. https:\/\/doi.org\/10.2340\/actadv.v105.43685","journal-title":"Acta Derm Venereol"},{"key":"4373_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr 43:181\u2013193. https:\/\/doi.org\/10.1002\/jpen.1451","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"4373_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010249","author":"Y Tan","year":"2024","unstructured":"Tan Y, Huang Z, Li H, Yao H, Fu Y, Wu X, Lin C, Lai Z, Yang G, Jing C (2024) Association between psoriasis and renal functions: an integration study of observational study and Mendelian randomization. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12010249","journal-title":"Biomedicines"},{"key":"4373_CR34","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","volume":"185","author":"LA Z\u00fa\u00f1iga","year":"2010","unstructured":"Z\u00fa\u00f1iga LA, Shen WJ, Joyce-Shaikh B et al (2010) IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 185:6947\u20136959. https:\/\/doi.org\/10.4049\/jimmunol.1001269","journal-title":"J Immunol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04373-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:01:20Z","timestamp":1783396880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04373-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4373"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04373-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Sel\u00e7uk University Faculty of Medicine Ethics Committee (approval number 2025\/223). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}